Asset Prioritization

Develop R&D strategy with reliable analysis of your asset group and come up focused list of prioritized assets.
Request for proposal

Our Perspective

DelveInsight’s Asset Prioritization methodology employs intuitive assessments to initiate the client’s R&D journey. DelveInsight’s analysts work with the client team to develop intelligent criteria, create assessment scenarios through reliable parameters of importance and define situations for consequence of possible successes and failures. Our Asset Prioritization service provides understanding future market dynamics through market modelling, unmet medical needs for future understanding of treatment regimens, and thus, help create a sound strategy for company’s research and development.
Our Asset Prioritization methodology provides:

Insights

Assest prioritization study

Asset Prioritization

A mid-sized pharma client was working to develop their asset portfolio, and was interested to assess best possible asset for atrial fibrillation [...]

Product assessment study

Product Assessment

A large pharma client was working to develop their cyclophosphamide API and FD, and was interested to assess competitive products [...]

Out-licensing opportunity study

Out-Licensing Opportunity

A Small Pharmaceutical Client Based At Sweden, Europe With Capabilities Around A Neonatal Mesenchymal Cells Involved DelveInsight [...]

Partner Identification study

Partner Identification

A medium pharmaceutical client based in the US, with innovative formulations to treat Head and Neck Cancer, involved DelveInsight to identify a co-development partner, for the US and European region. [...]

Request For Proposal

I consent to DelveInsight gathering details provided via this form. Check our Privacy Policy to know more.

Request For Proposal

*I consent to DelveInsight gathering details provided via this form. Check our Privacy Policy to know more.